Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Brain Neoplasms 4Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Cysts 1Myofibroma 1Liver Neoplasms 1Encephalocele 1Cholecystitis 1Breast Neoplasms 1

Interventions

Radiosurgery 7lenvatinib 5Radiofrequency Ablation 5Electroporation 5Radiotherapy 3Patient Navigation 3Laparoscopy 3Hepatectomy 3Exercise 3sintilimab 2perflutren 2Surgical Procedures, Operative 2Standard of Care 2Proton Therapy 2Nutritional Status 2Magnetic Resonance Spectroscopy 2Liver Transplantation 2Injections 2Dextrins 2Cryosurgery 2Control Groups 2Bupivacaine 2Anesthesia, General 2toripalimab 1tislelizumab 1seocalcitol 1pembrolizumab 1motexafin gadolinium 1gadofosveset trisodium 1gadobutrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Liver Neoplasms × Remifentanil × Clear all
NCT06003218 2025-04-02

Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation

Peking University First Hospital

Phase NA Completed
88 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡